Jamie Smith
Media Relations
Email: jamie.smith@molnlycke.com
Phone: +46 722-553573
Gothenburg, Sweden. 12 November 2025. Mölnlycke Health Care, a global leader in MedTech, is the first company to donate a patent to SKF’s groundbreaking digital platform, The Patent Bay – taking bold action to harness collaboration and accelerate innovation in sustainable healthcare.

“We are proud to be part of this pioneering initiative,” says Zlatko Rihter, CEO of Mölnlycke Health Care. “Our purpose is to revolutionise care for people and planet. Supporting The Patent Bay is a powerful way to help turn that purpose into action.”
Today’s healthcare systems are under immense pressure to deliver the right care to the right patients, often with fewer resources. Mölnlycke believes that embracing partnerships, collaboration and openness are key to overcoming these challenges. By contributing to The Patent Bay, Mölnlycke is helping unlock new opportunities to help shape more sustainable healthcare systems for the future.
Mölnlycke is sharing a patent family relating to a method to determine a patient’s risk score. The innovation uses patient data to help caregivers predict risks and tailor treatments more effectively. By comparing a patient’s health profile to large-scale models, the patented method may improve treatment accuracy, reduce unnecessary interventions and lower healthcare costs.
Mölnlycke is making its patent freely accessible to innovators, entrepreneurs, researchers and healthcare providers worldwide, with the ultimate aim to improve patient outcomes.
“The Patent Bay was founded to accelerate progress through open knowledge and shared innovation. Mölnlycke Health Care’s decision to share smarter patient risk scoring highlights the power of collaboration—enabling better care and advancing healthcare for all. It’s a clear reminder that sharing drives meaningful progress for people, society and the planet,” says Annika Ölme, CTO and Senior Vice President, Technology Development at SKF.
Zlatko Rihter adds, “We encourage other organisations to join us in contributing to The Patent Bay to help drive open innovation for a more sustainable future.”
For more information please contact:

Media Relations
Email: jamie.smith@molnlycke.com
Phone: +46 722-553573
Note to editors
About The Patent Bay
The Patent Bay is a unique platform for sharing patents related to sustainable development, free of charge. It aims to accelerate technologies with the potential to advance sustainability through openness and collaboration. By taking a new approach to industrial innovation and rethinking how it is shared, it removes traditional barriers around patents – making sustainable technologies freely accessible, without the complex licensing or governance structures that often slow collaboration. The initiative reflects a shift from ownership to openness, and represents a practical, collaborative approach to industrial responsibility in the climate era. thepatentbay.com
Changshu, China, and Gothenburg, Sweden. 5 November 2025. Mölnlycke® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, is celebrating the commencement of its new wound care manufacturing site in Changshu, China. This strategic investment marks a milestone in Mölnlycke’s growth journey and the beginning of localised manufacturing in one of the world’s fastest-growing MedTech markets
Gothenburg, Sweden, 15 October 2025 Mölnlycke® Health Care is proud to announce that its global headquarters have placed number one in Sweden, and top 20 globally, in the prestigious Leesman® Index, a benchmark survey measuring workplace experience across thousands of organisations worldwide.
Brunswick, Maine, USA and Gothenburg, Sweden. 23 September 2025. Mölnlycke® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, today celebrates the groundbreaking of a major expansion to its wound care manufacturing capacity in Brunswick, Maine. This milestone marks the beginning of a $135 million investment aimed at significantly increasing Mölnlycke’s manufacturing capacity in the United States.
Gothenburg, Sweden. 17 September 2025. A new narrative review published in the current issue of Journal of Patient Safety, titled ’Putting Patients at Risk: The Effect of Health Care Provider Burnout on Patient Care in the Operating Room’ reveals alarmingly high levels of burnout among healthcare workers in operating rooms (ORs) and warns of the serious implications for staff well-being, care quality and ultimately patient safety.
Gothenburg, Sweden. 21 August 2025. Mölnlycke®, a world-leading MedTech company, has once again been recognised as a global sustainability leader, earning the prestigious EcoVadis Platinum medal for the second year in a row.
A new peer-reviewed study published in the Journal of Hospital Infection underscores the critical role of double gloving and indicator systems in reducing the risk of undetected glove breaches during surgery.
Gothenburg, Sweden, 26 June 2025. Mölnlycke Health Care, a global leader in MedTech, today announces its largest investment to date: a €115 million expansion of its wound care manufacturing capacity in Brunswick, Maine, USA.
Stockholm/Gothenburg – 24 June, 2025. Mölnlycke Health Care and The Swedish Export Credit Corporation (SEK) have signed a USD 400 million financing agreement to support the healthcare company’s continued global growth and development.